Status:
COMPLETED
Usability of a Breathing-CBT Platform (CBT = Cognitive Behavioural Therapy)
Lead Sponsor:
ResMed
Conditions:
Breathing, Mouth
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The study will examine the usability of a breathing platform in the home environment. It will be a randomized, open-label crossover study of 10 participants who will complete the CBT and breathing com...
Eligibility Criteria
Inclusion
- Participants are willing to give written, informed consent
- Participants are healthy adults
- Participants are able to comprehend and speak English
- Participants are at least 18 years of age
Exclusion
- Participants who are/may be pregnant or lactating
- Participant that have a pre-existing lung disease/ condition that would predispose them to pneumothorax (for example: COPD, lung cancer; fibrosis of the lungs; recent (\< 2years) case of pneumonia or lung infection; lung injury)
- Participants who are unsuitable for the inclusion at the discretion of the investigator
Key Trial Info
Start Date :
June 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 30 2018
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04776122
Start Date
June 1 2018
End Date
July 30 2018
Last Update
March 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ResMed Ltd
Sydney, Australia